No Data
No Data
Express News | El En Spa - Yofc to Subscribe to 2.5 Million Euro Capital Increase in Cutlite Penta
Express News | El En Spa - to Retain 19.3% Stake in Penta Laser Zhejiang, 30% in Cutlite Penta
Changyingtong (688143.SH): continues suspension of trading.
GeLongHui November 7th - Changyingtong (688143.SH) announced that the company plans to acquire 100% of the shares of wuhan Shengyisheng Optoelectronic Technology Co., Ltd. (referred to as the "target company" or "Shengyisheng") through the issuance of shares and payment of cash to wuhan Chualian Zhiguang Technology Co., Ltd., Li Longqin, Ningbo Chengfenghao Enterprise Management Co., Ltd., and other three trading parties, and raise matching funds. As of the date of this announcement, all parties involved are actively advancing various work related to this transaction, and the company expects that trading will not resume from the morning of Friday, November 8, 2024. Due to the significant uncertainties in the above matters.
Yangtze Optical Electronic (SHSE:688143) Posted Weak Earnings But There Is More To Worry About
Changyintong (688143.SH): The company has accumulated repurchased 0.7653% of its own shares.
Galunhui November 4th | Changyingtong (688143.SH) announced that as of October 31, 2024, the company has repurchased a total of 936,588 shares of the company through the Shanghai Stock Exchange trading system by centralized competitive trading method, accounting for 0.7653% of the company's current total share capital of 122,374,426 shares. The highest price for repurchase transactions was 23.86 yuan/share, the lowest price was 16.10 yuan/share, and the total amount paid was RMB 17,983,323.36 (excluding stamp duty, transaction commission and other transaction fees).
Changyong Technology (688143.SH) plans to issue additional shares for acquisition, starting from November 1st, the trading of shares will be suspended.
ChangYingTong (688143.SH) announced that the company is planning to purchase wuhan life through the issuance of shares and cash payment...
No Data
No Data